Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 4 |
| List of Tables | 4 | 1 |
| List of Figures | 5 | 1 |
| AcelRx Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 | 5 | 2 |
| AcelRx Pharmaceuticals, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 | 7 | 1 |
| AcelRx Pharmaceuticals, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 | 8 | 1 |
| AcelRx Pharmaceuticals, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 | 9 | 1 |
| AcelRx Pharmaceuticals, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 | 10 | 1 |
| AcelRx Pharmaceuticals, Inc., Medical Equipment, Deal Details | 11 | 11 |
| Venture Financing | 11 | 1 |
| AcelRx Pharma Raises US$8 Million In Venture Financing | 11 | 1 |
| Partnerships | 12 | 1 |
| AcelRx Pharma Amends Commercialization Agreement With Grunenthal For Zalviso | 12 | 1 |
| Equity Offering | 13 | 1 |
| AcelRx Pharma Completes Public Offering Of Shares For US$51 Million | 13 | 2 |
| AcelRx Pharma Completes Underwriters' Exercise Of Over-Allotment Option For US$6 Million | 15 | 2 |
| AcelRx Pharma Completes Private Placement Of Units For US$10 Million | 17 | 1 |
| AcelRx Pharma Completes IPO Of US$40 Million | 18 | 2 |
| Asset Transactions | 20 | 1 |
| PDL BioPharma Acquires Portion of Zalviso Royalty Rights from AcelRx Pharma for USD65 Million | 20 | 2 |
| AcelRx Pharmaceuticals, Inc. - Key Competitors | 22 | 1 |
| Key Employees | 23 | 1 |
| Locations And Subsidiaries | 24 | 1 |
| Head Office | 24 | 1 |
| Other Locations &Subsidiaries | 24 | 1 |
| Recent Developments | 25 | 1 |
| Financial Announcements | 25 | 1 |
| Jul 28, 2016: AcelRx Pharmaceuticals Provides Corporate Update and Reports Second Quarter and Six Months 2016 Financial Results | 25 | 3 |
| Mar 07, 2016: AcelRx Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2015 Financial Results | 28 | 2 |
| Oct 29, 2015: AcelRx Pharmaceuticals Provides Business Update and Reports Third Quarter and Nine Months 2015 Financial Results | 30 | 2 |
| Aug 03, 2015: AcelRx Pharmaceuticals Provides Business Update and Reports Second Quarter and Six Months 2015 Financial Results | 32 | 2 |
| May 04, 2015: AcelRx Pharmaceuticals Reports First Quarter 2015 Financial Results | 34 | 1 |
| Mar 09, 2015: AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2014 Financial Results | 35 | 1 |
| Corporate Communications | 36 | 1 |
| Mar 29, 2016: AcelRx Pharmaceuticals Names Howard B. Rosen as Chief Executive Officer and Provides Update on Clinical Development Activities and Corporate Priorities for 2016 | 36 | 1 |
| Oct 01, 2015: AcelRx Pharmaceuticals Appoints Gina Ford as Vice President Commercial Strategy | 37 | 1 |
| Mar 20, 2015: AcelRx Appoints Howard B. Rosen as Interim CEO | 38 | 1 |
| Product News | 39 | 1 |
| Sep 22, 2015: AcelRx Pharmaceuticals Reports that the European Commission has Granted Marketing Authorization for Zalviso for Treatment of Acute Moderate-to-Severe Post-Operative Pain in Adult Patients | 39 | 1 |
| Product Approvals | 40 | 1 |
| Sep 22, 2015: AcelRx Pharmaceuticals Reports that the European Commission has Granted Marketing Authorization for Zalviso for Treatment of Acute Moderate-to-Severe Post-Operative Pain in Adult Patients | 40 | 1 |
| Appendix | 41 | 1 |
| Methodology | 41 | 1 |
| About GlobalData | 41 | 1 |
| Contact Us | 41 | 1 |
| Disclaimer | 41 | 1 |